by McKesson Ventures | Apr 21, 2026 | Media Coverage
Michelle Snyder, McKesson Ventures’ Partner and host of the Breaking Health podcast, recently spoke with Atropos Health CEO and co-founder Brigham Hyde, PhD on an episode of the show. Snyder interviewed Hyde about impressive movements that companies have been making...
by McKesson Ventures | Jan 12, 2026 | Press Releases
Real-world clinical data provider Atropos Health has announced that it will be making its Commercial Analytics solutions available to life science leaders. This new offering will harness the speed, accuracy, and efficiency of the company’s AI-powered ChatRWD®...
by McKesson Ventures | Nov 18, 2025 | Press Releases
Real-world data-based healthcare technology company Atropos Health recently announced the launch of an integration between the company’s Atropos Evidence™ Agent and Microsoft Teams. This agent allows for real-world evidence (RWE) to be generated at the touch of a...
by McKesson Ventures | Aug 18, 2025 | Press Releases
On Monday, August 18th, real-world clinical data company Atropos Health announced that it has partnered with innovative medicines company Novartis to help train and improve medical AI models used to detect paroxysmal nocturnal hemoglobinuria (PNH). This rare disease...
by McKesson Ventures | Apr 28, 2025 | Press Releases
On Monday, April 28th, clinical real-world data (RWD) company Atropos Health announced that it would be collaborating with community oncology real-world data (RWD) provider Ontada to enhance oncology data use cases for clinicians, researchers, and healthcare leaders —...
